Subscribe to RSS
DOI: 10.1055/s-2008-1078252
Sulfur Ylide Mediated Three-Component Aziridination and Epoxidation Reactions Using Vinyl Sulfonium Salts
Publication History
Publication Date:
05 August 2008 (online)
Abstract
Coupling of diphenylvinyl sulfonium triflate with nucleophiles and either aldehydes or imines gives epoxides and aziridines, respectively, in a three-component reaction. cis-Aziridines could be formed in good diastereomeric ratio, and the selectivity was correlated to the reactivity of the imine. This represents the first study of cis/trans selectivity in the reactions of imines with nonstabilized sulfur ylides.
Key words
sulfur ylides - epoxidations - aziridinations - multicomponent reactions - vinyl sulfonium salts
- Reviews:
-
1a
Syamala M. Org. Prep. Proced. Int. 2005, 37: 103 -
1b
Noyori R.Suzuki M. Chemtracts 1990, 3: 173 -
2a
Yar M.McGarrigle EM.Aggarwal VK. Angew. Chem. Int. Ed. 2008, 47: 3784 ; Angew. Chem. 2008, 120, 3844 -
2b
Unthank MG.Tavassoli B.Aggarwal VK. Org. Lett. 2008, 10: 1501 -
2c
Unthank MG.Hussain N.Aggarwal VK. Angew. Chem. Int. Ed. 2006, 45: 7066 ; Angew. Chem. 2006, 118, 7224 -
3a
Kim K.Jimenez LS. Tetrahedron: Asymmetry 2001, 12: 999 -
3b
Wang Y.Zhang W.Colandrea VJ.Jimenez LS. Tetrahedron 1999, 55: 10659 - There is one isolated report of an epoxidation reaction of a butadienylsulfonium salt with a β-keto ester and aldehyde. See:
-
4a
Rowbottom MW.Mathews N.Gallagher T. J. Chem. Soc., Perkin Trans. 1 1998, 3927 - For a related example using vinyl selenonium salts, see:
-
4b
Watanabe Y.Ueno Y.Toru T. Bull. Chem. Soc. Jpn. 1993, 66: 2042 - 5
Corey EJ.Oppolzer W. J. Am. Chem. Soc. 1964, 86: 1899 - Nucleophiles with two acidic protons on the same atom have been shown to react with vinyl sulfonium salts to give three-membered rings:
-
6a
Gosselck J.Béress L.Schenk H. Angew. Chem., Int. Ed. Engl. 1966, 5: 596 ; Angew. Chem. 1966, 78, 606 -
6b
Johnson CR.Lockard JP. Tetrahedron Lett. 1971, 12: 4589 -
6c
Takaki K.Agawa T. J. Org. Chem. 1977, 42: 3303 -
6d
Matsuo J.Yamanaka H.Kawana A.Mukaiyama T. Chem. Lett. 2003, 32: 392 - In cases where the nucleophile can be resonance-stabilized forming enolates, five-membered rings have also been obtained:
-
6e
Braun H.Huber G. Tetrahedron Lett. 1976, 17: 2121 -
6f
Batty JW.Howes PD.Stirling CJM. J. Chem. Soc., Perkin Trans. 1 1973, 65 ; ref. 6b - For leading references on aziridination reactions of sulfonium methylides with imines, see:
-
7a
Aggarwal VK.Coogan MP.Stenson RA.Jones RVH.Fieldhouse R.Blacker J. Eur. J. Org. Chem. 2002, 319 -
7b
Aggarwal VK.Stenson RA.Jones RVH.Fieldhouse R.Blacker J. Tetrahedron Lett. 2001, 42: 1587 - For leading references on aziridinations with other types of sulfur ylides, see:
-
8a
McGarrigle EM.Myers EL.Illa O.Shaw MA.Riches SL.Aggarwal VK. Chem. Rev. 2007, 107: 5841 -
8b
Hou XL.Wu J.Fan RH.Ding CH.Luo ZB.Dai LX. Synlett 2006, 181 -
8c
Tang Y.Ye S.Sun X.-L. Synlett 2005, 2720 -
8d
Aggarwal VK.Badine DM.Moorthie VA. In Aziridines and Epoxides in Asymmetric SynthesisYudin AK. Wiley-VCH; Weinheim: 2006. Chap. 1. - Only cis-aziridine was obtained in the reaction of(dimethylamino)-p-tolyloxosulfonium ethylide with PhCH=NPh, see:
-
8e
Johnson CR.Janiga ER. J. Am. Chem. Soc. 1973, 95: 7692 - 9
Aggarwal VK.Charmant JPH.Ciampi C.Hornby JM.O’Brien CJ.Hynd G.Parsons R. J. Chem. Soc., Perkin Trans. 1 2001, 3159 -
10a
Robiette R. J. Org. Chem. 2006, 71: 2726 -
10b
Janardanan D.Sunoj RB. Chem. Eur. J. 2007, 13: 4805 - 11
Seebach D.Golinsky J. Helv. Chim. Acta 1981, 64: 1413
References and Notes
The products were characterized by NMR, IR, MS, and mp (where appropriate). Satisfactory elemental analyses and/or HRMS were obtained for all compounds. Full details and spectra are available from the authors.
13N ,4-Dimethyl- N -{[1-(toluene-4-sulfonyl)-3-phenyl-2-aziridinyl]methyl}benzenesulfonamide (Table 2, Entry 2) cis-Isomer as a colourless oil; R f = 0.40 (EtOAc-PE, 3:7). IR (film): 1598 (Ar), 1330 (SO2), 1160 (SO2) cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 7.86 (2 H, d, J = 8.3 Hz, ArH), 7.50 (2 H, d, J = 8.3 Hz, ArH), 7.35 (2 H, d, J = 8.3 Hz, ArH), 7.27-7.16 (7 H, m, ArH), 3.93 (1 H, d, J = 7.0 Hz, NCHPh), 3.25-3.14 (2 H, m, NCHH and NCHCH2), 2.53 (1 H, dd, J = 14.3, 7.0 Hz, NCHH), 2.44 (6 H, s, 2 × CH3), 2.38 (3 H, s, CH3). ¹³C NMR (100.5 MHz, CDCl3): δ = 145.0 (C), 143.5 (C), 136.2 (C), 135.9 (C), 132.0 (C), 130.0 (CH), 129.9 (CH), 129.7 (CH), 128.6 (CH), 128.3 (CH), 127.4 (CH), 127.3 (CH), 47.6 (CH2), 44.4 (CH), 44.1 (CH), 35.4 (CH3), 21.7 (CH3), 21.5 (CH3). MS (CI): m/z (%) = 471 (14) [MH+], 198 (100) [Ts(Me)NCH2 +]; trans-isomer (obtained as a mixture with cis-isomer) as a colorless oil; R f = 0.40 (EtOAc-PE, 3:7). IR (film): νmax = 1599 (Ar), 1332 (SO2), 1161 (SO2) cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 7.77 (2 H, d, J = 8.3 Hz, ArH), 7.69 (2 H, d, J = 8.3 Hz, ArH), 7.31 (2 H, d, J = 8.3 Hz, ArH), 7.26-7.19 (7 H, m, ArH), 3.85 (1 H, d, J = 3.8 Hz, NCHPh), 3.55 (1 H, dd, J = 14.6, 8.6 Hz, NCHH), 3.03 (1 H, ddd, J = 8.6, 8.6, 3.8 Hz, NCHCH2N), 2.43 (6 H, s, 2 × CH3), 2.42-2.38 (4 H, m, NCHH and CH3). ¹³C NMR (100.5 MHz, CDCl3): δ = 144.9 (C), 143.6 (C), 136.2 (C), 134.0 (C), 132.0 (C), 129.9 (CH), 129.8 (CH), 128.6 (CH), 128.5 (CH), 127.4 (CH), 127.3 (CH), 126.9 (CH), 49.6 (CH), 49.0 (CH2), 48.8 (CH), 36.5 (CH3), 21.7 (CH3), 21.5 (CH3). MS (CI): m/z (%) = 471 (14) [MH+], 198 (100) [Ts(Me)NCH2 +].
14
Diethyl 2-Methyl-2-({1-[(4-methylphenyl)sulfonyl]-3-phenyl-2-aziridinyl}methyl)malonate
(Table 3, Entry 3)
cis/trans-Isomers (3:1) as a colorless oil
(89%); R
f
= 0.30 (EtOAc-PE,
2:8). IR (film): 1761 (OCO), 1162 (SO2) cm-¹. ¹H
NMR (400 MHz, CDCl3): δ(cis) = 7.85
(2 H, d, J = 8.3 Hz, ArH), 7.32-7.17
(7 H, m, ArH), 4.19-4.02 (4 H, m, 2 × OCH2),
3.87 (1 H, d, J = 7.2 Hz, NCHPh),
2.99-2.91 (1 H, m, NCHCH2), 2.43 (3 H, s, CH3),
1.87 (1 H, dd, J = 14.9, 5.8 Hz,
CHH), 1.70 (1 H, dd, J = 14.9,
6.4 Hz, CHH), 1.31 (3 H, s, CH3),
1.27-1.11 (6 H, m, 2 × CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 171.5 (C),
171.4 (C), 144.7 (C), 144.6 (C), 132.4 (C), 129.8 (CH), 129.6 (CH),
128.5 (CH), 128.2 (CH), 127.6 (CH), 61.8 (CH2), 61.6
(CH2), 52.4 (C), 45.1 (CH), 42.7 (CH), 31.1 (CH2),
21.6 (CH3), 19.5 (CH3), 13.9 (CH3),
13.8 (CH3). ¹H NMR (400 MHz, CDCl3): δ(trans) = 7.78 (2 H, d, J = 8.3 Hz, ArH), 7.32-7.17
(7 H, m, ArH), 4.19-4.02 (4 H, m, 2 × OCH2),
3.78 (1 H, d, J = 4.2 Hz, NCHPh),
2.99-2.91 (1 H, m, NCHCH2), 2.49-2.36
(5 H, m, CH2 and CH3), 1.31 (3 H, s, CH3),
1.27-1.11 (6 H, m, 2 × CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 171.5 (C),
171.4 (C), 144.4 (C), 143.6 (C), 134.8 (C), 129.8 (CH), 128.8 (CH),
128.5 (CH), 127.4 (CH), 126.7 (CH), 61.8 (CH2), 61.7
(CH2), 52.9 (C), 46.2 (CH), 43.7 (CH), 31.9 (CH2),
21.6 (CH3), 20.7 (CH3), 13.9 (CH3),
13.8 (CH3). MS (CI): m/z (%) = 460
(28) [MH+] , 414 (17) [M+ - EtO],
286 (100) [M+ - C(CO2Et)2Me].
1-(4-Toluenesulfonyl)-2-phenyl-3-[(phenylsul-fanyl)methyl]aziridine
(Table 3, Entry 6)
cis:trans-Isomers (1:5) as a colorless oil
(33%); R
f
= 0.45 (EtOAc-PE,
3:7). IR (film): 1347 (SO2), 1164 (SO2) cm-¹. ¹H
NMR (400 MHz, CDCl3): δ(cis) = 7.58
(2 H, d, J = 8.3 Hz, ArH), 7.35-7.08
(12 H, m, ArH), 4.03 (1 H, d, J = 7.0 Hz,
NCHPh), 3.29-3.19 (2 H, m, NCHCHH), 2.62 (1 H, dd, J = 14.2,
7.0 Hz, CHH), 2.36 (3 H, s, CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 143.5 (C),
137.0 (C), 135.2 (C), 134.6 (C), 129.8 (CH), 129.7 (CH), 129.1 (CH),
128.8 (CH), 128.1 (CH), 127.7 (CH), 127.1 (CH), 126.6 (CH), 46.2
(CH), 45.1 (CH), 35.4 (CH2), 21.6 (CH3). ¹H
NMR (400 MHz, CDCl3): δ(trans) = 7.81
(2 H, d, J = 8.3 Hz, ArH), 7.35-7.08
(12 H, m, ArH), 4.70 (1 H, d, J = 4.2
Hz, NCHPh), 3.73 (1 H, ddd, J = 7.0,
6.5, 4.2 Hz, NCHCH2), 3.12
(1 H, dd, J = 14.1, 6.5 Hz,
CHH), 2.81 (1 H, dd, J = 14.1,
7.0 Hz, CHH), 2.42 (3 H, s, CH3). ¹³C
NMR (100.5 MHz, CDCl3): δ = 144.7 (C),
137.2 (C), 135.0 (C), 134.4 (C), 129.9 (CH), 129.7 (CH), 129.6 (CH),
129.2 (CH), 129.0 (CH), 128.9 (CH), 128.2 (CH), 127.4 (CH), 48.9
(CH), 46.3 (CH), 35.6 (CH2), 21.7 (CH3). MS
(CI): m/z (%) = 396
(3) [MH+], 224 (100) [MH+ - TsNH2],
155 (16) [Ts+].
Diethyl 2-(Acetylamino)-2-{[3-(4-methoxyphenyl)-1-(4-toluene-sulfonyl)-2-aziridinyl]methyl}malonate (Table 4, Entry 8) cis-Isomer as a colorless oil (62%); R f = 0.40 (EtOAc-PE, 4:6). IR (film): 1762 (OCO), 1160 (SO2) cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 7.79 (2 H, d, J = 8.3 Hz, ArH), 7.29 (2 H, d, J = 8.3 Hz, ArH), 7.21 (1 H, br s, NH), 6.95 (2 H, d, J = 8.7 Hz, ArH), 6.75 (2 H, d, J = 8.7 Hz, ArH), 4.41-4.09 (4 H, m, 2 × OCH2), 3.74 (1 H, d, J = 7.2 Hz, NCHAr), 3.73 (3 H, s, OCH3), 2.89 (1 H, ddd, J = 10.1, 7.2, 3.7 Hz, NCHCH2), 2.53 (1 H, dd, J = 15.1, 3.7 Hz, CHH), 2.41 (3 H, s, CH3), 2.10 (1 H, dd, J = 15.1, 10.1 Hz, CHH), 2.07 (3 H, s, CH3), 1.33-1.15 (6 H, m, 2 × CH3). ¹³C NMR (100.5 MHz, CDCl3): δ = 169.7 (C), 167.4 (C), 167.2 (C), 159.5 (C), 144.9 (C), 131.1 (C), 129.8 (CH), 128.5 (CH), 128.1 (CH), 123.8 (C), 114.0 (CH), 65.1 (C), 62.9 (CH2), 62.7 (CH2), 55.3 (CH3), 45.1 (CH), 41.1 (CH), 28.9 (CH2), 23.0 (CH3), 21.8 (CH3), 14.0 (CH3), 13.9 (CH3). MS (CI): m/z (%) = 533 (58) [MH+], 320 (100) [MH+ - TsNHAc].